The Global synthetic stem cell market size is expected to grow from $14 million in 2023 to $37 million by 2028, at a CAGR of 22.5%.

Currently, Artificial Stem Cells technology is co-developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).

In line with the rising importance of stem cell, researcher Ke Cheng, an associate professor at North Carolina State University, and his research partner Dr. Thomas Caranasos of the University of North Carolina School of Medicine created a protocol to harvest the healing factors secreted by the heart stem cells and encapsulate them synthetically.

Don’t miss out on business opportunities in Synthetic Stem Cells Market by Application

Synthetic Stem Cells Market by Application

The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Artificial Stem Cells Market

https://www.marketsandmarkets.com/Market-Reports/synthetic-stem-cells-market-4959435.html

Synthetic Stem Cells Market by Application:

By application, the cardiovascular diseases segment accounted for the largest share during the forecast period.

The major applications of Artificial Stem Cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.

Download PDF ( Artificial Stem Cells Market ): 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435

Geographical Analysis of Synthetic Stem Cells Market:

North America is expected to account for the largest Artificial Stem Cells Market share during the forecast period.

North America is estimated to account for the largest share of the market in 2023. This is majorly attributed to the rising research on stem cells in the region, coupled with public-private funding. The region is a global leader in the research on regenerative therapies such as stem cells and is backed by funding on advanced research infrastructure to commercialize novel regenerative therapies. Moreover, North America is the pioneer of synthetic stem cell technology and will be the early adopter of this technology in the coming years.

Click to Read More in Detail about synthetic stem cell technology:

https://www.marketsandmarkets.com/Market-Reports/synthetic-stem-cells-market-4959435.html